Balan Gets Research into the Right Hands

Fundamental research builds the foundations of the technology we use and enjoy every day. Hundreds of developments are made annually by facilities in research centers and universities. How best though to get those discoveries to the people and industries who might benefit the most. Our relationship with the biomedical industry, medical professionals and the patient consumer places Balan in a unique position to aid you in evaluating your technology portfolio for their medical potential. Balan facilitates the necessary adaptations a technology may need to gain medical use approvals.

For Research Labs with extensive technology portfolios, Balan offers the expertise and experience to evaluate your technology for potential application in health care. The process of technology evaluation and match to clinical needs offers advantages to both research labs and device manufacturers. The Balan process brings a systematic analysis and matching of solutions to needs that increases the likelihood of success and mitigates the risk that chance discovery brings with it. Research labs see increased revenue through licensing to new markets and device manufacturers see enhancement of existing product through application of novel technology or reduced product development timelines through early partnerships with researchers and inventors.

We can enhance the technology, but should we?

In this case the Balan client was the Technology Transfer Office of a prestigious research facility One of the faculty members had an idea to enhance the information gathered from a diagnostic device. The question from the TTO was “Is this data clinically useful, and if so, will physicians and healthcare systems be willing to pay the additional amount for the enhanced device?” The Balan Physician Network of cardiologists, cardiothoracic surgeons and electrophysiologists was queried. It was learned that 5 years ago the enhancement would have been useful but current practice, based on existing diagnostic options, which didn’t exist 5 years ago, left the current enhancement without substantial clinical improvement. This is information was given to our client with the result that internal university resources were deployed where greater commercial success was likely.